Physician profile
August Conner
NPI 1760059729
$3,447.62
in general payments reported to CMS, 2019-2025
24 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $622 · 2022: $782 · 2023: $630 · 2024: $354 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,023 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,023.01 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $775.70 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals Lp | $495.14 | 2021-2025 | Farxiga, Wainua |
| Aop Health US, LLC | $354.08 | 2025 | Rapiblyk |
| Boehringer Ingelheim Pharmaceuticals, INC. | $354.05 | 2021-2025 | Jardiance |
| Pfizer INC. | $177.79 | 2022-2025 | |
| Irhythm Technologies, INC. | $174.01 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Atricure, INC. | $169.91 | 2022 | |
| Janssen Pharmaceuticals, INC | $168.01 | 2022-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $160.78 | 2022-2025 | |
| Edwards Lifesciences Corporation | $86.42 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $81.08 | 2023-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $74.27 | 2023-2024 | |
| Kestra Medical Technology Services, INC. | $68.99 | 2024-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.43 | 2021 | |
| Lantheus Medical Imaging, INC. | $41.98 | 2024-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $39.11 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $34.42 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $25.18 | 2023 | Nexletol |
| Impulse Dynamics (USA) INC. | $23.81 | 2022 | |
| Cardiva Medical, INC. | $19.55 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Regeneron Healthcare Solutions, INC. | $19.42 | 2025 | Evkeeza |
| Alnylam Pharmaceuticals INC. | $16.44 | 2025 | Onpattro |
| Novo Nordisk INC | $15.72 | 2023 | Ozempic |
| Abbott Laboratories | $13.33 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw August Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.